The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of temsirolimus (TEM) plus sorafenib (SOR) in hepatocellular carcinoma (HCC).
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma (Inst); Exelixis (Inst); Lilly (Inst)
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Regeneron (Inst)
 
Halla Sayed Nimeiri
Honoraria - Genentech; Novartis
 
John Dozier Gordan
Research Funding - Daiichi Sankyo (Inst)
 
Jimmy Hwang
No Relationships to Disclose
 
Ryan M. McWhirter
No Relationships to Disclose
 
Advaita Kanakamedala
No Relationships to Disclose
 
Chloe Evelyn Atreya
Speakers' Bureau - Bayer
Research Funding - GlaxoSmithKline
 
Laura Kulik
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bayer/Onyx; Gilead Sciences
Research Funding - Bayer/Onyx
Travel, Accommodations, Expenses - Gilead Sciences
 
Sheetal Kircher
No Relationships to Disclose
 
Mary Frances Mulcahy
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; Merck Serono; Merck/Schering Plough; Sanofi; Spectrum Pharmaceuticals
Research Funding - advanced accelerator applications; Amgen; Astellas Pharma; Bayer/Onyx; Genentech (I); Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Roche